Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis
Science Advances · 2026
DOI: 10.1126/sciadv.adz5906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Wei Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium. Hauptthemen laut MEDLINE: Caspase 3, Caspase 7, Colitis, Carcinogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fonds Wetenschappelijk Onderzoek, Universiteit Gent, Stichting Tegen Kanker.
Abstract (Originalsprache)
Aberrant intestinal epithelial cell (IEC) death is common in inflammatory bowel disease (IBD) and related animal models. While various cell death pathways contribute to disease, the dominant modalities and their regulatory mechanisms in intestinal inflammation remain ill defined. Using the DSS colitis model, we examined the contribution of apoptosis ( Casp3/7 Δ IEC ), necroptosis ( Mlkl Δ IEC ), pyroptosis ( Gsdme Δ IEC , Gsdmd −/− ) , and ferroptosis ( Gpx4 i Δ IEC ) in IECs. Mice lacking caspase-3/7 in IECs showed worsened colitis, higher mortality, and impaired regeneration, not seen in the other transgenic mice. Caspase-3/7 deficiency in IECs hindered stem cell proliferation and increased inflammatory cell death, disrupting barrier integrity and delaying recovery. Despite heightened inflammation, Casp3/7 Δ IEC mice had reduced tumor formation in the AOM/DSS-induced colorectal cancer model. These findings highlight a protective role for caspase-3/7 in controlling inflammation and tissue regeneration, while promoting tumorigenesis following intestinal injury, and suggest modulation of caspase-3/7 as a promising therapeutic strategy in IBD and colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium.
- Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
- Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
- Molecular and Cellular Oncology Laboratory, Ghent University, Ghent, Belgium.
- VIB BioImaging Core, VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium.
- Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
ORCID-Profile: Wei Xie, Laura Wyckaert, Mike Vadi, Bruno Verstraeten, Tatyana Divert, Jef Haerinck, Riet De Rycke, Femke Baeke, Geert Berx, Adam Wahida, Peter Vandenabeele
Förderung
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- Stichting Tegen Kanker
Zitieren
APA
Xie, W., Wyckaert, L., Vadi, M., Verstraeten, B., Divert, T., Haerinck, J., De Rycke, R., Baeke, F., Lamkanfi, M., Berx, G., Wahida, A., & Vandenabeele, P. (2026). Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis. Science Advances. https://doi.org/10.1126/sciadv.adz5906
Vancouver
Xie W, Wyckaert L, Vadi M, Verstraeten B, Divert T, Haerinck J, et al. Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis. Science Advances. 2026. doi:10.1126/sciadv.adz5906
BibTeX
@article{Xie2026,
author = {Xie, Wei and Wyckaert, Laura and Vadi, Mike and Verstraeten, Bruno and Divert, Tatyana and Haerinck, Jef and De Rycke, Riet and Baeke, Femke and Lamkanfi, Mohamed and Berx, Geert and Wahida, Adam and Vandenabeele, Peter},
title = {Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz5906}
}
EUVIMED